1. Factor VII assay performance: an analysis of the North American Specialized Coagulation Laboratory Association proficiency testing results. Issue 3 (17th April 2013) Authors: Zantek, N. D.; Hsu, P.; Refaai, M. A.; Ledford‐Kraemer, M.; Meijer, P.; Van, E. M. Journal: International journal of laboratory hematology Issue: Volume 35:Issue 3(2013:Jun.) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Quality of factor XI activity testing in North American Specialized Coagulation Laboratories. (14th May 2015) Authors: Zantek, N. D.; Hsu, P.; Meijer, P.; Smock, K. J.; Plumhoff, E. A.; Refaai, M. A.; Van Cott, E. M. Journal: International journal of laboratory hematology Issue: Volume 37:(2015) Supplement 1 Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO‐incompatible haematopoietic stem cell transplantation. Issue 3 (9th May 2014) Authors: Khan, F.; Linden, M. A.; Zantek, N. D.; Vercellotti, G. M. Journal: Transfusion medicine Issue: Volume 24:Issue 3(2014) Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗